본문 바로가기
KERD
논문KCI 등재후보

단일 요법 항경련제가 소아 골밀도에 미치는 영향

Effects of Anticonvulsant Monotherapy on Bone Mineral Density in Children

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류신경과학

초록

목적: 항경련제 사용은 골밀도 감소와 같은 부작용을 일으킬 수 있고 지속적으로 성장하는 소아에서 주의가 필요하다. 단일 요법으로치료하는 뇌전증 환자에서 항경련제가 골밀도에 미치는 영향의 차이를 알아보고자 하였다. 방법: 2013년 1월부터 2017년 12월까지 부천성모병원에서 뇌전증치료를 하는 소아 환자 60명에 대해 후향적으로 살펴 보았다. Dual photo absorptiometry로 골밀도를 6개월마다 측정하였다. 결과: 전체 60명 중 Oxcarbazepine, Valproate, Levetiracetam으로 치료한 환자는 각각 31, 16, 13명이었다. Oxcarbazepine 치료 환자 31명 중 8명(25.8%, P =0.10), Valproate 치료 환자 16명 중 9명(56.3%, P =0.04), Levetiracetam 치료 환자 13명 중 4명(30.8%, P=0.50)에서 골밀도 감소가 관찰되었다. 결론: Valproate 투여 환자들에서 다른 항경련제 치료 환자보다 골밀도가 유의하게 감소되었다. 항경련제 치료를 하는 소아 뇌전증 환자의 골밀도에 대한 관심이 필요할 것으로 생각된다.

Abstract

Purpose: The use of anticonvulsants can cause side effects such as reduction of bone mineral density, requiring attention in growing children. The aim of our study is to investigate the effects of different anticonvulsants on bone mineral density in epileptic patients treated with monotherapy. Methods: We retrospectively reviewed medical records of 60 subjects who visited the Pediatric Epilepsy Clinic of Bucheon St. Mary’s Hospital from January 2013 to December 2017. Bone mineral density was measured with dual photon absorptiometry every 6 months. Results: The number of patients treated with oxcarbazepine, valproate and levetiracetam was 31, 16 and 13, respectively. Reduction of bone mineral density was seen in 8 out of 31 patients (25.8%, P=0.10) treated with oxcarbazepine, 9 out of 16 patients treated with valproate (56.3%, P=0.04) and 4 out of 13 patients treated with levetiracetam (30.8%, P=0.50). Conclusion: There was a significant reduction of bone mineral density in patients treated with valproate compared to the other anticonvulsants in our study. We believe attention to bone mineral density is required in children treated with anticonvulsants.

참고문헌 (18)

  1. Jacoby A, "Epilepsy and social identity: the stigma of a chronic neurological disorder", Lancet Neurol, 4, pp.171~178 (2005)
  2. Sheth RD., "Bone health in pediatric epilepsy", Epilepsy Behav, 5(Suppl 2), pp.S30~S35 (2004)
  3. Coppola G, "Bone mineral density in children, adolescents, and young adults with epilepsy", Epilepsia, 50, pp.2140~2146 (2009)
  4. Aronson E, "Bone health in children with cerebral palsy and epilepsy", J Pediatr Health Care, 26, pp.193~199 (2012)
  5. McNamara NA, "Bone health and endocrine comorbidities in pediatric epilepsy", Semin Pediatr Neurol, 24, pp.301~309 (2017)
  6. Gissel T, "Adverse effects of antiepileptic drugs on bone mineral density in children", Expert Opin Drug Saf, 6, pp.267~278 (2007)
  7. Trevathan E., "Epilepsy-associated bone mineral density loss should be prevented", Neurology, 70, pp.166~167 (2008)
  8. Binkovitz LA, "Pediatric dual-energy X-ray absorptiometry: technique, interpretation, and clinical applications", Semin Nucl Med, 37, pp.303~313 (2007)
  9. Gordon CM, "Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions", J Clin Densitom, 11, pp.43~58 (2008)
  10. Chung S, "Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children", Brain Dev, 16, pp.382~385 (1994)
  11. Erbayat Altay E, "Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid", J Pediatr Endocrinol Metab, 13, pp.933~939 (2000)
  12. Tekgul H, "Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy", J Child Neurol, 21, pp.411~414 (2006)
  13. 고진희, "Bone Mineral Density in Ambulatory Epileptic Children with New Antiepileptic Drug Monotherapy", 대한소아신경학회지, 19(3), pp.184~190 (2011), 대한소아신경학회[DOI]
  14. Hasaneen B, "Bone mineral status in children with epilepsy:biochemical and radiologic markers", J Pediatr Neurosci, 12, pp.138~143 (2017)
  15. Stoffel-Wagner B, "Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication", Epilepsia, 39, pp.1164~1173 (1998)
  16. Rättyä J, "Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy", Neurology, 56, pp.31~36 (2001)
  17. Morrell MJ, "Reproductive dysfunction in women with epilepsy:antiepileptic drug effects on sex-steroid hormones", CNS Spectr, 6, pp.771~772 (2001)
  18. Kühn-Velten WN, "Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis", Eur J Pharmacol, 181, pp.151~155 (1990)

관련 논문AI추천

Bone Mineral Density in Ambulatory Epileptic Children with New Antiepileptic Drug Monotherapy고진희, 이규민, 이은혜, 정사준대한소아신경학회 · 대한소아신경학회지2011 · 제19권 제3호Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment김건하, 김미경, 백정현, 서영호, 은백린연세대학교의과대학 · Yonsei Medical Journal2014 · 제55권 제2호May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?A. Karaoglu, B. Unay, E. Yesilkaya, M. Gulgun, O. Babacan, O. Ozcan, O. Yesilyurt, R. Akın, S. Vurucu, T. Cayci대한신경과학회 · Journal of Clinical Neurology2012 · 제8권 제1호항경련제에 의한 골밀도 감소와 골대사 변화의 기전강은숙, 김숙희, 김용재, 이진화, 이향운, 정혜원, 최경규대한신경과학회 · 대한신경과학회지2005 · 제23권 제6호Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with EpilepsyBaki Arpacı, Betül Tekin Güveli, Dilek Ataklı, Duygu Aksoy, Hüseyin Sarı, Pelin Doğan Ak대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호청소년 근간대 뇌전증에서 발프로인산 하루 한번 투약 용법의 효용성과 안정성황희, 김기중, 김수연, 김헌민, 류혜원, 유일한, 임병찬, 채종희, 최선아, 최지은, 황용승대한소아신경학회 · 대한소아신경학회지2014 · 제22권 제2호

이 간행물의 다른 논문 (17건)